The Food and Drug Administration (FDA) announced on July 12 that it is updating the label on the Johnson & Johnson COVID-19 vaccine to include a warning about the risk of developing Guillain-Barré ...

Zika fever is an emerging infectious disease of arboviral origin transmitted by mosquitoes of Aedes genus. It presents as an influenza-like disease with a cutaneous rash, but certain complications can ...

A new study from Israel indicates that COVID-19 is associated with an elevated risk of a rare disorder, Guillain-Barré syndrome, within six weeks after infection with the virus. Photo by Ian ...

Both Pfizer and GSK’s upcoming respiratory syncytial virus (RSV) vaccines had instances of Guillain-Barré syndrome in clinical trials. And yet the FDA is only recommending that one of them conduct a ...

Experts say there has been an increase in a rare syndrome called Guillain Barré in Peru. The condition can occur when the immune system attacks the nervous system after either a viral or bacterial ...

Researchers found a link between covid-19 and Guillain-Barré syndrome, while also finding that mRNA vaccination may lower the risk. Reading time 3 minutes New research links the rare neurological ...

Guillain-Barré syndrome is a neurological, autoimmune condition characterized by rapidly developing muscle weakness in affected individuals. The syndrome usually follows a period of sickness such as a ...

Miller Fisher syndrome is a very rare nerve disease that’s related to Guillain-Barré syndrome (GBS). Guillain-Barré syndrome affects about one in 100,000 people. In the U.S., it’s estimated that 3,000 ...

Not all Guillain-Barré cases are associated with infection, and studies have suggested a link between the rare disorder and certain cancers, including lymphomas. Certain cancers, such as lymphomas, ...

PROMPTED by the apparently increasing interest in the Guillain—Barré syndrome, judging from the literature, we consider it appropriate to review 17 cases of this clinical complex observed at ...